Medicine and Dentistry
Acetylsalicylic Acid
7%
Acute Coronary Syndrome
11%
Acute Heart Infarction
5%
Adipose Tissue
8%
Apoplexy
59%
Arteriosclerosis Obliterans
11%
Atherosclerosis
25%
Atmospheric Aerosols
5%
Behavioral Risk Factor Surveillance System
6%
Beta Adrenergic Receptor Blocking
6%
Beta Adrenergic Receptor Blocking Agent
5%
Biological Marker
6%
Birth Outcomes
5%
Blood Pressure
12%
Cardiology
17%
Cardiovascular Disease
100%
Cardiovascular Disease Prevention
27%
Cardiovascular Disease Risk Factor
9%
Cardiovascular Mortality
7%
Cardiovascular Risk
15%
Cardiovascular System
87%
Chronic Kidney Disease
9%
Clinical Management
6%
Clinical Trial
8%
Clinician
40%
Cohort Analysis
6%
Cohort Effect
6%
Combination Therapy
12%
Comorbidity
6%
Computed Tomography Angiography
6%
Congestive Heart Failure
26%
Coronary Angiography
6%
Coronary Artery Calcium
22%
Coronary Artery Disease
36%
Coronary Computed Tomography Angiography
11%
Cross Sectional Study
8%
Decision Making
12%
Diabetes
17%
Diabetes Mellitus
8%
Digital Health
6%
Disease
9%
Disease Burden
6%
Disease Management
8%
Diseases
52%
Drug Therapy
7%
Dyslipidemia
6%
Ethnic Groups
6%
Hazard Ratio
8%
Health Behavior
8%
Health Care
6%
Health Care Cost
16%
Heart Disease
51%
Heart Failure with Reduced Ejection Fraction
5%
Hemoglobin A1c
5%
High Risk Population
6%
Ischemic Heart Disease
21%
Lipoprotein
14%
Logistic Regression Analysis
6%
Low Density Lipoprotein Cholesterol
23%
Malignant Neoplasm
5%
Medical Procedures
5%
Metabolic Syndrome
12%
middle age
5%
Mortality Rate
15%
Myocardial Infarction
12%
Neonatal Infant
8%
Noncardiac Surgery
6%
Odds Ratio
9%
Patient Referral
5%
Patient with Type 2 Diabetes
11%
Persistent Truncus Arteriosus
5%
Physical Activity
7%
Prematurity
10%
Prevalence
15%
Preventive Cardiology
13%
Primary Prevention
17%
Prospective Cohort Study
5%
Randomized Controlled Trial
8%
Rhythm
5%
Risk Stratification
6%
Sleep Quality
5%
Small for Gestational Age
5%
Social Determinants of Health
14%
Social Isolation
5%
Socioeconomic Status
5%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Statin
26%
Systematic Review
7%
Systolic Blood Pressure
8%
Triacylglycerol
9%
Vascular Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
7%
Acute Heart Infarction
6%
All Cause Mortality
10%
Atherosclerosis
17%
Beta Adrenergic Receptor Blocking Agent
5%
Biological Marker
6%
Cardiovascular Disease
87%
Cardiovascular Mortality
5%
Cardiovascular Risk
13%
Cerebrovascular Accident
37%
Chronic Kidney Failure
7%
Clinical Trial
9%
Cohort Study
7%
Combination Therapy
9%
Congestive Heart Failure
33%
Coronary Artery Atherosclerosis
21%
Coronary Artery Disease
21%
Diabetes Mellitus
5%
Diseases
37%
Familial Hypercholesterolemia
5%
Global Disease Burden
7%
Heart Disease
31%
Heart Failure with Reduced Ejection Fraction
5%
Heart Infarction
14%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Hyperlipidemia
5%
Inclisiran
5%
Ischemic Heart Disease
10%
Lipoprotein A
9%
Low Density Lipoprotein Cholesterol
22%
Mortality Rate
13%
Non Insulin Dependent Diabetes Mellitus
6%
Peripheral Occlusive Artery Disease
8%
Prevalence
19%
Randomized Controlled Trial
5%
Sleep Disorder
6%
Small Interfering RNA
5%
Statin (Protein)
15%
Triacylglycerol
10%
Social Sciences
Action Research
11%
Africa
5%
Assessment for Learning
6%
Authors
11%
Cardiovascular Disease
11%
Developing Countries
5%
Discourse
5%
East Africa
12%
Education Program
6%
English
11%
In-service Teachers
5%
Inservice Teacher Education
6%
Language of Instruction
11%
Low Income
5%
Mathematics Education
33%
Multilingualism
16%
Occupational Career
5%
Pakistan
66%
Participant Observation
6%
Preventive Medicine
6%
Professional Development
10%
Public Education
5%
Secondary School Teacher
6%
Semi-Structured Interview
6%
Social Integration
10%
Student Learning
9%
Tanzania UR
11%
Teacher Beliefs
10%
Teacher Learning
10%
Teacher Professional Development
10%
Teaching Mathematics
5%
Training Development
5%
Training Opportunities
6%
USA
6%